Blockers in Acute Decompensated Heart Failure wmshp受体阻滞剂在急性失代偿性心力衰竭 课件.ppt

Blockers in Acute Decompensated Heart Failure wmshp受体阻滞剂在急性失代偿性心力衰竭 课件.ppt

  1. 1、本文档共69页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Blockers in Acute Decompensated Heart Failure wmshp受体阻滞剂在急性失代偿性心力衰竭 课件

Beta Blockers in Acute Decompensated Heart Failure Foranow GC. J Am Coll Cardiol 2008;52:190-9 The Hospitalized Patient In patients hospitalized with HF with reduced ejection fraction not treated with oral therapies known to improve outcomes, particularly ACE inhibitors or ARBs and beta-blocker therapy, initiation of these therapies is recommended in stable patients prior to hospital discharge. Initiation of beta-blocker therapy is recommended after optimization of volume status and successful discontinuation of intravenous diuretics, vasodilators, and inotropic agents. Beta-blocker therapy should be initiated at a low dose and only in stable patients. Particular caution should be used when initiating beta-blockers in patients who have required inotropes during their hospital course. New New In patients with evidence of severely symptomatic fluid overload in the absence of systemic hypotension, vasodilators such as intravenous nitroglycerin, nitroprusside or neseritide can be beneficial when added to diuretics and/or in those who do not respond to diuretics alone. The Hospitalized Patient Severe Symptomatic Fluid Overload New I IIa IIb III The Hospitalized Patient Comprehensive written discharge instructions for all patients with a hospitalization for HF and their caregivers is strongly recommended, with special emphasis on the following 6 aspects of care: diet, discharge medications, with a special focus on adherence, persistence, and uptitration to recommended doses of ACE inhibitor/ARB and beta-blocker medication, activity level, follow-up appointments, weight monitoring, and what to do if HF symptoms worsen. Reconciling and Adjusting Medications New Recommendations for Hospital Discharge /content/early/2013/06/03/CIR.0b013e31829e8776.citation Improvement of Guideline Beta-Blocker Prescribing in Heart Failure: A Cluster-Randomized Pragmatic Trial of a Pharmacy Intervention We conducted a pragmatic cluster-randomized trial, where facilities (n 5 12) with

文档评论(0)

2017meng + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档